Infliximab/mesalazine/corticosteroidsDevelopment of resistance to infliximab and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82429-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：149 / 149

相关论文

共 50 条

[1] Infliximab/Mesalazine/PrednisoloneDrug-induced liver injury and lack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 185 - 185
[2] Infliximab/vancomycinAllergy and lack of efficacy: case report
Reactions Weekly, 2023, 1969 (1) : 198 - 198
[3] Infliximab/vedolizumabLupus and lack of efficacy : case report
Reactions Weekly, 2023, 1967 (1) : 203 - 203
[4] Infliximab/mesalazine/methotrexateLack of efficacy and miliary TB: case report
Reactions Weekly, 2022, 1909 (1) : 292 - 292
[5] Infliximab/mesalazine/vedolizumabLack of efficacy and acute tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1971 (1) : 137 - 137
[6] Infliximab/salbutamol/steroidsAnaphylaxis and lack of efficacy: case report
Reactions Weekly, 2024, 2028 (1) : 249 - 249
[7] Infliximab/mesalazineDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 232 - 232
[8] Infliximab/mesalazineEosinophilic pneumonitis and lack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 268 - 268
[9] Infliximab/prednisoneCytomegalovirus infection and lack of efficacy: case report
Reactions Weekly, 2021, 1884 (1) : 227 - 227
[10] Infliximab/prednisoneTransverse myelitis and lack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 423 - 423

← 1 2 3 4 5 →